Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × Secondary Prevention × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Breast 1

Conditions

Lymphoma 1 Heart Failure 1 Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Rituximab 2 Lenalidomide 2 pegfilgrastim 1 obinutuzumab 1 acalabrutinib 1 Vincristine 1 Vascular Stiffness 1 Secondary Prevention 1 Pulse Wave Analysis 1 Prednisolone 1 Exercise 1 Eplerenone 1 Electrocardiography 1 Echocardiography 1 Doxorubicin 1 Dexrazoxane 1 Cyclophosphamide 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05892146 2023-06-07

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

National Cheng-Kung University Hospital

Phase NA Unknown

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡